Clinical Trials Directory

Trials / Completed

CompletedNCT01897350

Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Elisa McAlindon · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Cardiac magnetic resonance imaging (CMR) is a non invasive technique used to obtain functional and anatomical information on the heart. Several CMR parameters measured after primary percutaneous coronary intervention (PPCI) have been shown to have prognostic value and are increasingly being used as surrogate endpoints in clinical trials. Myocardial oedema is a prognostic indicator following myocardial infarction1. Myocardial salvage is calculated as the myocardial oedema minus infarct size; this again is a prognostic indicator following STEMI. However, myocardial oedema imaging is controversial. There are multiple sequences available, with no standardisation of sequences used to assess this surrogate endpoint. The investigators propose to conduct a study to measure the myocardial oedema by all available techniques to determine the agreement between these methods.

Conditions

Interventions

TypeNameDescription
OTHERCardiac magnetic resonance imaging

Timeline

Start date
2013-07-01
Primary completion
2013-12-01
First posted
2013-07-12
Last updated
2014-10-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01897350. Inclusion in this directory is not an endorsement.